Persistence of vaccinia at the site of smallpox vaccination
| Autor: | James F. Cummings, Glenn Wortmann, Mary M. Klote, Clifton A. Hawkes, George V. Ludwig, Mark E. Polhemus |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Microbiology (medical)
business.industry Transmission (medicine) Vaccinia virus medicine.disease Virology Vaccination chemistry.chemical_compound Infectious Diseases chemistry Immunization Antigen Immunology Medicine Smallpox Humans Viral disease Prospective Studies Vaccinia business Smallpox vaccine Smallpox Vaccine |
| Zdroj: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 46(1) |
| ISSN: | 1537-6591 |
| Popis: | Persistence of vaccinia at vaccination sites may help determine the risk associated with secondary transmission. Culture, PCR, and antigen detection were performed on serial vaccination site swab specimens. On day 21 after vaccination, 37% of volunteers were culture positive, most of whom had received vaccine for the first time. Vaccinia is detectable at least through day 21 after vaccination. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|